HYL.BR BRU
Hyloris Pharmaceuticals S.A.
1W: -5.6%
1M: -6.5%
3M: -4.1%
YTD: -43.4%
1Y: -35.4%
3Y: -64.0%
5Y: -68.4%
€4.20 ($4.69)
-0.05 (-1.18%)
Weekly Expected Move ±5.8%
€4
€4
€4
€4
€5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$33M
-19.3% ▼
5Y CAGR: -13.6%
Total Liabilities
$7M
-25.1% ▼
5Y CAGR: -7.4%
Shareholders Equity
$26M
-17.6% ▼
5Y CAGR: -14.8%
Cash & Investments
$14M
-43.0% ▼
5Y CAGR: -26.5%
Total Debt
$2M
-6.5% ▼
5Y CAGR: -27.5%
Net Debt
-$12M
+44.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $50M | $43M | $30M | $24M | $14M |
| Short-Term Investments | $528K | $0 | $0 | $556K | $0 |
| Cash & ST Investments | $51M | $43M | $30M | $24M | $14M |
| Net Receivables | $2M | $4M | $4M | $5M | $6M |
| Inventory | $0 | $0 | $0 | $0 | $52K |
| Other Current Assets | $0 | $469K | $743K | $508K | $491K |
| Total Current Assets | $54M | $50M | $35M | $30M | $20M |
| Property, Plant & Equip. | $295K | $1M | $2M | $2M | $2M |
| Goodwill & Intangibles | $3M | $4M | $4M | $4M | $6M |
| Long-Term Investments | $4M | $4M | $5M | $4M | $6M |
| Other Non-Current Assets | $2M | $6M | $2M | $2M | $1K |
| Total Non-Current Assets | $9M | $11M | $12M | $12M | $13M |
| Total Assets | $63M | $62M | $48M | $41M | $33M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $2M | $3M | $3M | $5M |
| Short-Term Debt | $12M | $3M | $0 | $0 | $364K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $47K | -$86K | $3M | $3M | $75K |
| Total Current Liabilities | $15M | $6M | $7M | $7M | $5M |
| Long-Term Debt | $300K | $0 | $0 | $0 | $1M |
| Other Non-Current Liab. | $1K | $300K | $343K | $541K | $416K |
| Total Non-Current Liabilities | $410K | $1M | $2M | $2M | $2M |
| Total Liabilities | $15M | $7M | $9M | $9M | $7M |
| — Equity — | |||||
| Common Stock | $129K | $140K | $140K | $140K | $140K |
| Retained Earnings | -$55M | -$65M | -$81M | -$86M | -$93M |
| Accumulated OCI | -$960K | -$2M | -$2M | -$4M | -$3M |
| Total Stockholders Equity | $48M | $54M | $39M | $32M | $26M |
| Total Liabilities & Equity | $63M | $62M | $48M | $41M | $33M |
| — Key Metrics — | |||||
| Total Debt | $12M | $885K | $2M | $2M | $2M |
| Net Debt | -$38M | -$43M | -$29M | -$22M | -$12M |
| Total Investments | $5M | $4M | $5M | $4M | $6M |